Cargando…
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome
Type I interferon (IFN) response initially limits HIV-1 spread and may delay disease progression by stimulating several immune system components. Nonetheless, persistent exposure to type I IFN in the chronic phase of HIV-1 infection is associated with desensitization and/or detrimental immune activa...
Autores principales: | Scagnolari, Carolina, Antonelli, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108411/ https://www.ncbi.nlm.nih.gov/pubmed/29576284 http://dx.doi.org/10.1016/j.cytogfr.2018.03.003 |
Ejemplares similares
-
Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use
por: Antonelli, Guido, et al.
Publicado: (2015) -
Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019
por: Khorramdelazad, Hossein, et al.
Publicado: (2022) -
Treatment of SARS with human interferons
por: Antonelli, Guido, et al.
Publicado: (2003) -
High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
por: Scordio, Mirko, et al.
Publicado: (2022) -
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients
por: Antonelli, Guido, et al.
Publicado: (2020)